Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection: insight from the observational multicentric ProREAL surveillance

[1]  P. Schuetz,et al.  Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL). , 2012, Archives of internal medicine.

[2]  P. Schuetz,et al.  Effectiveness and Safety of Procalcitonin-Guided Antibiotic Therapy in Lower Respiratory Tract Infections in "Real Life" , 2012 .

[3]  S. Harbarth,et al.  At least it won't hurt: the personal risks of antibiotic exposure. , 2011, Current opinion in pharmacology.

[4]  R. Maganti,et al.  Neurotoxic effects associated with antibiotic use: management considerations. , 2011, British journal of clinical pharmacology.

[5]  R. Gruen,et al.  Evidence-based medicine training and implementation in surgery: the role of surgical cultures. , 2011, Journal of evaluation in clinical practice.

[6]  G. Dumyati,et al.  Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Brad Spellberg,et al.  The antibiotic crisis: can we reverse 65 years of failed stewardship? , 2011, Archives of Internal Medicine.

[8]  J. Bartlett.  Diagnostic tests for agents of community-acquired pneumonia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  A. Schwartz,et al.  Medical Decision Making and Medical Education: Challenges and Opportunities , 2011, Perspectives in biology and medicine.

[10]  R. Haspel.  Implementation and assessment of a resident curriculum in evidence-based transfusion medicine. , 2010, Archives of pathology & laboratory medicine.

[11]  M. Christ-Crain,et al.  Procalcitonin for guidance of antibiotic therapy , 2010, Expert review of anti-infective therapy.

[12]  R. Grol,et al.  Antibiotic prescribing in hospitals: a social and behavioural scientific approach. , 2010, The Lancet. Infectious diseases.

[13]  F. Tubach,et al.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.

[14]  H. Goossens,et al.  Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. , 2010, The Lancet. Infectious diseases.

[15]  P. Schuetz,et al.  Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[16]  M. Fine,et al.  Reasons why emergency department providers do not rely on the pneumonia severity index to determine the initial site of treatment for patients with pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  T. Bregenzer,et al.  Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. , 2009, JAMA.

[18]  P. Böelle,et al.  Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 , 2009, PLoS medicine.

[19]  H. Goossens,et al.  Antimicrobial Drug Use and Resistance in Europe , 2008, Emerging infectious diseases.

[20]  Marc Lipsitch,et al.  Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy? , 2008, The Journal of infectious diseases.

[21]  T. Bregenzer,et al.  Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial , 2007, BMC Health Services Research.

[22]  R. Wenzel,et al.  Clinical practice. Acute bronchitis. , 2006, The New England journal of medicine.

[23]  M. Filippini,et al.  Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. , 2006, Health policy.

[24]  S. Harbarth,et al.  Navigating the World Wide Web in search of resources on antimicrobial resistance. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  M. Christ-Crain,et al.  Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. , 2006, American journal of respiratory and critical care medicine.

[26]  S. Cosgrove.  The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Karin Hannes,et al.  Implementing evidence-based medicine in general practice: a focus group based study , 2005, BMC family practice.

[28]  S. Ringer,et al.  Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. , 2004, Clinical Infectious Diseases.

[29]  Stephan Harbarth,et al.  Antibiotic Selection Pressure and Resistance in Streptococcus pneumoniae and Streptococcus pyogenes , 2004, Emerging infectious diseases.

[30]  M. Christ-Crain,et al.  Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial , 2004, The Lancet.

[31]  J. Metlay,et al.  Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. , 2004, The Lancet. Infectious diseases.

[32]  S. Cosgrove,et al.  The impact of antimicrobial resistance on health and economic outcomes. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  C. Brun-Buisson,et al.  Outpatient Antibiotic Use and Prevalence of Antibiotic-Resistant Pneumococci in France and Germany: A Sociocultural Perspective , 2002, Emerging infectious diseases.

[34]  D. Goldmann,et al.  Control of multiply resistant cocci: do international comparisons help? , 2001, The Lancet. Infectious diseases.

[35]  O. Cars,et al.  Variation in antibiotic use in the European Union , 2001, The Lancet.

[36]  R. Gonzales,et al.  Uncomplicated Acute Bronchitis , 2000, Annals of Internal Medicine.

[37]  J. Grimshaw,et al.  Evidence-based implementation of evidence-based medicine. , 1999, The Joint Commission journal on quality improvement.

[38]  Y. Carmeli,et al.  Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. , 1999, Archives of internal medicine.

[39]  J. Steiner,et al.  Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. , 1997, JAMA.